← ANALYST RATINGS · TIPRANKS
Inspire Medical Systems (INSP): analyst forecast and price target
Analyst consensus
Hold3 Buy6 Hold2 Sell
Ratings of 11 analysts in the last 3 months · top analysts only12-month forecast
Based on 11 price targets given in the last 3 months, the average target is $65.64, the highest $85.00, the lowest $45.00. The average is −4.6% from the last price of $68.79.
Analyst ratings 21
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Richard Newitter★★★★★★★★★★#1772 · hits 48% · avg +6.6% | Truist Financial | $62.00 → $78.00+25.8% | Hold | +13.4% | Reiterated | 14.10.26on TipRanks 08:35 | −0.1%next day +2.7% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $65.00 → $75.00+15.4% | Buy | +9.0% | Assigned | 13.10.26on TipRanks 07:35 | −3.7%next day −0.1% | ↗ |
| Unknown Analyst | Leerink Partners | $59.00 → $67.00+13.6% | Hold | −2.6% | Reiterated | 12.10.26on TipRanks Oct 13 07:35 | +3.8%next day −3.7% | ↗ |
| Unknown Analyst | Barclays | $65.00 | Sell | −5.5% | Initiated | 06.10.26on TipRanks Oct 7 00:05 | −4.2%next day −0.9% · 5 days +1.1% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $83.00 → $80.00−3.6% | Buy | +16.3% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $83.00 → $81.00−2.4% | Buy | +17.7% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $81.00 → $78.00−3.7% | Buy | +13.4% | Upgrade | 03.10.26on TipRanks 00:06 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $78.00 → $75.00−3.8% | Hold | +9.0% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $83.00 → $81.00−2.4% | Buy | +17.7% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $83.00 → $80.00−3.6% | Buy | +16.3% | Reiterated | 03.10.26on TipRanks 00:06 | — | |
| Adam Maeder★★★★★★★★★★#1026 · hits 54% · avg +11.3% | Piper Sandler | $60.00 | Hold | −12.8% | Reiterated | 02.10.26on TipRanks 07:35 | −1.9%next day +0.4% · 5 days −2.7% | ↗ |
| Shagun Singh Chadha★★★★★★★★★★#9557 · hits 48% · avg −0.4% | RBC Capital | $60.00 → $75.00+25.0% | Hold | +9.0% | Reiterated | 01.10.26on TipRanks 07:55 | +1.9%next day −1.9% · 5 days −7.1% | ↗ |
| Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% | Stifel Nicolaus | $80.00 → $85.00+6.2% | Buy | +23.6% | Reiterated | 22.09.26on TipRanks 22:05 | −2.4%next day −0.3% · 5 days +1.1% | ↗ |
| Keith Hinton★★★★★★★★★★#7123 · hits 80% · avg +7.0% | Freedom Capital Markets | $71.00 → $97.00+36.6% | Buy | +41.0% | Reiterated | 21.09.26on TipRanks 06:20 | −2.9%next day −5.8% · 5 days −6.5% | ↗ |
| Robbie Marcus★★★★★★★★★★#1974 · hits 51% · avg +6.5% | J.P. Morgan | $54.00 → $60.00+11.1% | Hold | −12.8% | Reiterated | 04.08.26on TipRanks 08:42 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Daniel Markowitz CFA★★★★★★★★★★#1752 · hits 61% · avg +22.3% | Evercore ISI | $40.00 → $54.00+35.0% | Hold | −21.5% | Reiterated | 04.08.26on TipRanks 08:06 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Travis Steed★★★★★★★★★★#3596 · hits 53% · avg +3.0% | Bank of America Securities | $39.00 → $45.00+15.4% | Sell | −34.6% | Reiterated | 04.08.26on TipRanks 07:56 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Suraj Kalia★★★★★★★★★★#1646 · hits 50% · avg +6.8% | Oppenheimer | $85.00 | Buy | +23.6% | Upgrade | 04.08.26on TipRanks 07:56 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Larry Biegelsen★★★★★★★★★★#2729 · hits 53% · avg +3.8% | Wells Fargo | $56.00 | Hold | −18.6% | Reiterated | 04.08.26on TipRanks 07:45 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| David Rescott★★★★★★★★★★#3448 · hits 49% · avg +5.1% | Robert W. Baird | $54.00 → $59.00+9.3% | Hold | −14.2% | Reiterated | 04.08.26on TipRanks 06:45 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Brett Fishbin★★★★★★★★★★#10514 · hits 45% · avg −3.0% | KeyBanc | — | Hold | — | Reiterated | 04.08.26on TipRanks 03:55 | +21.0%next day −6.1% · 5 days −7.7% | ↗ |
| Name not given | — | $60.00 | Hold | −12.8% | Reiterated | 03.08.26on TipRanks Aug 5 21:45 | +2.6%next day +21.0% · 5 days +12.3% | ↗ |
| Patrick Wood★★★★★★★★★★#10768 · hits 50% · avg −2.1% | UBS | $67.00 → $39.00−41.8% | Sell | −43.3% | Downgrade | 28.07.26on TipRanks 06:40 | +1.8%next day −0.2% · 5 days +19.3% | ↗ |
| Michael Polark★★★★★★★★★★#2909 · hits 51% · avg +6.5% | Wolfe Research | — | Hold | — | Downgrade | 13.02.26on TipRanks 05:55 | +0.1%next day +0.9% · 5 days −2.6% | ↗ |
| Christopher Pasquale★★★★★★★★★★#1776 · hits 61% · avg +11.9% | Nephron | — | Hold | — | Downgrade | 12.02.26on TipRanks 07:20 | −11.0%next day +0.1% · 5 days −1.4% | ↗ |
| Michael Sarcone★★★★★★★★★★#4693 · hits 45% · avg +6.5% | Jefferies | — | Hold | — | Reiterated | 22.12.25on TipRanks 09:15 | +0.8%next day −3.5% · 5 days −5.8% | ↗ |
| Unknown Analyst | Roth MKM | $175 | Buy | +154.4% | Upgrade | 08.12.25on TipRanks Dec 24 10:00 | +5.5%next day −2.3% · 5 days −16.8% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Inspire Medical Systems
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $64.77 at a price of $69.36 (−6.6%); now: $66.67 at $68.79 (−3.1%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 8 | 6 | 3 | 3 | 5 | 6 |
| Hold | 9 | 10 | 11 | 9 | 8 | 8 |
| Sell | 1 | 1 | 1 | 1 | 1 | 2 |
Earnings and sales forecast
Next report: 02.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.09 (from $-0.13 to $0.17). Last quarter: $0.14.
Sales
Next quarter’s sales estimate — $204M (from $203M to $207M). Last quarter: $201M.
Best top-analyst consensus in the sector · Healthcare
About Inspire Medical Systems
- CEO: Timothy Herbert
- Employees: 1,333
- 5500 Wayzata Boulevard, Golden Valley, MN, 55416, US
- www.inspiresleep.com
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.
Data from the stock’s TipRanks forecast page, read 13 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗